Fetal Stem Cell Therapy Trialed for Brittle Bone Disease

Osteogenesis Imperfecta (OI), or brittle bone disease, is most commonly a genetic condition that affects the production of collagen in the body, leading to bones that can break very easily. People with OI also often suffer from loose joints, fatigue, early hearing loss and respiratory problems. SelectScience spoke to Dr Cecilia Gӧtherström, a researcher at the Karolinska Institutet in Stockholm, Sweden, and coordinator of the first clinical trial to pit stem cell therapy against this debilitating disorder.

To see more click here.

Leave a Reply

Your email address will not be published. Required fields are marked